Similar articles

• An improved method for genotyping of N-acetyltransferase polymorphism by polymerase chain reaction.

  Abe M, Suzuki T, Deguchi T. Abe M, et al. Jpn J Hum Genet. 1993 Jun;38(2):163-8. doi: 10.1007/BF01883706. Jpn J Hum Genet. 1993. PMID: 8102908
• [The genetically determined polymorphism of metabolic oxidation of the sparteine-debrisoquin type].

  Piotrovskiĭ VK, Belolipetskaia VG. Piotrovskiĭ VK, et al. Farmakol Toksikol. 1991 Nov-Dec;54(6):60-6. Farmakol Toksikol. 1991. PMID: 1804700 Review. Russian. No abstract available.
• [Clinical aspects of the polymorphism of oxidation phenotype].

  Mrozikiewicz PM. Mrozikiewicz PM. Pol Tyg Lek. 1992 Jul 6-13;47(27-28):608-10. Pol Tyg Lek. 1992. PMID: 1488339 Review. Polish. No abstract available.
• Determination of human NAT2 acetylator genotype by restriction fragment-length polymorphism and allele-specific amplification.

  Doll MA, Fretland AJ, Deitz AC, Hein DW. Doll MA, et al. Anal Biochem. 1995 Nov 1;231(2):413-20. doi: 10.1006/abio.1995.9978. Anal Biochem. 1995. PMID: 8594994
• Polymorphisms in drug-metabolizing enzymes: what is their clinical relevance and why do they exist?

  Nebert DW. Nebert DW. Am J Hum Genet. 1997 Feb;60(2):265-71. Am J Hum Genet. 1997. PMID: 9012398 Free PMC article. Review. No abstract available.